Skip to search formSkip to main contentSkip to account menu

sampatrilat

Known as: N-(1-(2-carboxy-3-(N(2)-mesyllysylamino)propyl)-1-cyclopentylcarbonyl)tyrosine 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

MesylatesProtease InhibitorsTyrosine

Narrower (1)

UK 81,252
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Neprilysin : Indications , Expectations , and Challenges Neprilisina : indicaciones , expectativas y retos
Neprilysin has become a focus of interest in cardiology, due to the impressive benefits of combining neprilysin inhibition and… 
2009
2009
OE-326 A Multi-Targeting Chronic Neurohumoral Therapy with Sampatrilat in Experimental Congestive Heart Failure : Neurohumoral, Renal and Clinical Actions(OE55,Heart Failure (Treatment) 2 (M),Oral…
1999
1999
Sampatrilat. UK 81252.